Although low LLGL2 mRNA expression was not an independent favorable prognostic factor in all breast cancer patients, we showed that low LLGL2 was an independent favorable prognostic factor for both DFS and OS in ERα-positive breast cancer patients, as well as nodal status (P = 0.012 and P = 0.011, respectively). This evidence concerns the gene LLGL2 and breast carcinoma.